Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar

Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar

Introduction Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in My...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Vickerman, Natasha K Martin, Adriane Wynn, Lara K Marquez, Antoine Chaillon, Kyi Pyar Soe, Derek C Johnson, Jean-Marc Zosso, Andrea Incerti, Anne Loarec, Aude Nguyen, Josephine G Walker, Nyashadzaishe Mafirakureva, Vincent Lo Re III, Craig McIntosh, Susan M Kiene, Stephanie Brodine, Richard S Garfein
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/6/2/e004181.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://gh.bmj.com/content/6/2/e004181.full

Similar Items